Nanocurcumin: a novel antifilarial agent with DNA topoisomerase II inhibitory activity

References

• WHO. Global programme to eliminate lymphatic filariasis. Weekly Epidemiol Rec 2011;437–44
   PubMedGoogle Scholar
• Melrose WD. Chemotherapy for lymphatic filariasis progress but not perfection. Expert Rev Anti Infect Ther 2003;1:571–7
   PubMedGoogle Scholar
• Silva ND. Global elimination of lymphatic filariasis, addressing the public health problem. PLoS Negl Trop Dis 2010;4:34–45
   Web of Science ®Google Scholar
• Gyapong JO, Kumaraswami V, Biswas G, et al. Treatment strategies underpinning the global programme to eliminate lymphatic filariasis. Expert Opin Pharmacother 2010;6:179–200
   Web of Science ®Google Scholar
• Singh PK, Ajay A, Kushwaha S, et al. Towards novel antifilarial drugs, challenges and recent developments. Future Med Chem 2010;2:251–83
   PubMed Web of Science ®Google Scholar
• Gupta S, Srivastava AK. Biochemical targets in filarial worms for selective antifilarial drug design. Acta Parasitol 2005;50:1–18
   Web of Science ®Google Scholar
• Tripathi RP, Rastogi SK, Kundu B, et al. Identification of inhibitors of DNA topoisomerase II from a synthetic library of glycoconjugates. Comb Chem High Throughput Screen 2001;4:237–44
   PubMed Web of Science ®Google Scholar
• Murthy PK, Joseph SK, Murthy PS. Plant products in the treatment and control of filariasis and other helminth infections and assay systems for antifilarial/anthelmintic activity. Planta Med 2011;77:647–61
   PubMed Web of Science ®Google Scholar
• Misra N, Sharma M, Raj K, et al. Chemical constituents and antifilarial activity of Lantana camara against human lymphatic filariid Brugia malayi and rodent filariid Acanthocheilonema viteae maintained in rodent hosts. Parasitol Res 2007;100:439–48
   PubMed Web of Science ®Google Scholar
• Kayser O, Kiderlen A, Croft S. Natural products as antiparasitic drugs. Parasitol Res 2003;90:55–62
   PubMed Web of Science ®Google Scholar
• Chatterjee RK, Fatma N, Murthy PK, et al. Macrofilaricidal activity of the stem bark of Streblus asper and its major active constituents. Drug Develop Res 1992;26:67–78
   Web of Science ®Google Scholar
• Nagajyothi F, Zhao D, Weiss LM, Tanowitz HB. Curcumin treatment provides protection against Trypanosoma cruzi infection. Parasitol Res 2012;110:2491–9
   PubMed Web of Science ®Google Scholar
• Sikora E, Zmijewska AB, Magalska A, et al. Curcumin induces caspase-3-dependent apoptotic pathway but inhibits DNA fragmentation factor 40/caspase-activated Dnase endonuclease in human jurkat cells. Mol Cancer Ther 2006;5:927–34
   PubMed Web of Science ®Google Scholar
• Shishodia S, Amin HM, Lai R, Aggarwal BB. Curcumin (diferuloylmethane) inhibits constitutive NF-κB activation, induces G1/S arrest, suppresses proliferation, and induces apoptosis in mantle cell lymphoma. Biochem Pharmacol 2005;70:700–13
   PubMed Web of Science ®Google Scholar
• Shishodia S, Sethi G, Aggarwal BB. Curcumin: getting back to the roots. Ann NY Acad Sci 2005;1056:206–17
   PubMed Web of Science ®Google Scholar
• Isacchi B, Bergonzi MC, Grazioso M, et al. Artemisinin and artemisinin plus curcumin liposomal formulations, enhanced antimalarial efficacy against Plasmodium berghei-infected mice. Eur J Pharm Biopharm 2012;80:528–34
   PubMed Web of Science ®Google Scholar
• Srinivasan L, Mathew N, Karunan T, et al. Biochemical studies on glutathione S-transferase from the bovine filarial worm Setaria digitata. Parasitol Res 2011;109:213–19
   PubMed Web of Science ®Google Scholar
• Magalhães LG, Machado CB, Morais ER, et al. In vitro schistosomicidal activity of curcumin against Schistosoma mansoni adult worms. Parasitol Res 2009;104:1197–201
   PubMed Web of Science ®Google Scholar
• Cui L, Miao J, Cui L, et al. Cytotoxic effect of curcumin on malaria parasite Plasmodium falciparum, inhibition of histone acetylation and generation of reactive oxygen species. Antimicrob Agents Chemother 2007;51:488–94
   PubMed Web of Science ®Google Scholar
• Gomes Dde C, Alegrio LV, de Lima ME, et al. Synthetic derivatives of curcumin and their activity against Leishmania amazonensis. Arzneimittelforschung 2002;52:120–4
   PubMed Web of Science ®Google Scholar
• Saleheen D, Ali SA, Ashfaq K, et al. Latent activity of curcumin against leishmaniasis in vitro. Biol Pharm Bull 2002;25:386–9
   PubMed Web of Science ®Google Scholar
• Nayak A, Gayen P, Saini P, et al. Molecular evidence of curcumin induced apoptosis in the filarial worm Setaria cervi. Parasitol Res 2012;111:1173–86
   PubMed Web of Science ®Google Scholar
• Azeez S, Babu RO, Aykkal R, Narayanan R. Virtual screening and in vitro assay of potential drug like inhibitors from spices against glutathione-S-transferase of filarial nematodes. J Mol Model 2012;18:51–63
   Web of Science ®Google Scholar
• Srinivasan L, Mathew N, Muthuswamy K. In vitro antifilarial activity of glutathione S transferase inhibitors. Parasitol Res 2009;105:1179–82
   PubMed Web of Science ®Google Scholar
• Wan S, Sun Y, Qi X, Tan F. Improved bioavailability of poorly water-soluble drug curcumin in cellulose acetate solid dispersion. AAPS PharmSciTech 2012;13:159–66
   PubMed Web of Science ®Google Scholar
• Mohanty C, Das M, Sahoo SK. Emerging role of nanocarriers to increase the solubility and bioavailability of curcumin. Expert Opin Drug Deliv 2012;9:1347–64
   PubMed Web of Science ®Google Scholar
• Prasanth R, Nair G, Girish CM. Enhanced endocytosis of nano-curcumin in nasopharyngeal cancer cells: an atomic force microscopy study. Appl Phys Lett 2011;99:163–76
   Web of Science ®Google Scholar
• Onoue S, Takahashi H, Kawabata Y, et al. Formulation design and photochemical studies on nanocrystal solid dispersion of curcumin with improved oral bioavailability. J Pharm Sci 2010;99:1871–81
   PubMed Web of Science ®Google Scholar
• Kurien BT, Singh A, Matsumoto H, Scofield RH. Improving the solubility and pharmacological efficacy of curcumin by heat treatment. Assay Drug Dev Technol 2007;5:567–76
   PubMed Web of Science ®Google Scholar
• Lim KJ, Bisht S, Bar EE, et al. A polymeric nanoparticle formulation of curcumin inhibits growth, clonogenicity and stem-like fraction in malignant brain tumors. Cancer Biol Ther 2011;11:464–73
   PubMed Web of Science ®Google Scholar
• Dandekar PP, Jain R, Patil S, et al. Curcumin-loaded hydrogel nanoparticles: application in anti-malarial therapy and toxicological evaluation. J Pharm Sci 2010;99:4992–501
   PubMed Web of Science ®Google Scholar
• Akhtar F, Rizvi MM, Kar SK. Oral delivery of curcumin bound to chitosan nanoparticles cured Plasmodium yoelii infected mice. Biotechnol Adv 2011;30:310–20
   PubMed Web of Science ®Google Scholar
• Nayak AP, Tiyaboonchai W, Patankar S, et al. Curcuminoids-loaded lipid nanoparticles: novel approach towards malaria treatment. Colloids Surf B Biointerfaces 2010;81:263–73
   PubMed Web of Science ®Google Scholar
• Ali M, Afzal M, Verma M, et al. Improved antifilarial activity of ivermectin in chitosan-alginate nanoparticles against human lymphatic filarial parasite, Brugia malayi. Parasitol Res 2013;112:2933–43
   PubMed Web of Science ®Google Scholar
• Ali M, Afzal M, Verma M, et al. Therapeutic efficacy of poly (lactic-co-glycolic acid) nanoparticles encapsulated ivermectin (nano-ivermectin) against brugian filariasis in experimental rodent model. Parasitol Res 2014. [Epub ahead of print]. doi: 10.1007/s00436-013-3696-5
   Google Scholar
• Bajpai P, Vedi S, Owais M, et al. Use of liposomized tetracycline in elimination of Wolbachia endobacterium of human lymphatic filariid Brugia malayi in a rodent model. J Drug Target 2005;13:375–81
   PubMed Web of Science ®Google Scholar
• Owais M, Misra-bhattacharya S, Haq W, Gupta CM. Immunomodulator tuftsin augments antifilarial activity of diethylcarbamazine against experimental Brugian Filariasis. J Drug Target 2003;11:247–51
   PubMed Web of Science ®Google Scholar
• Bisht S, Karikar C, Maitra A, et al. Polymeric nanoparticle encapsulated curcumin (“nanocurcumin”): a novel strategy for human cancer therapy. J Nanobiotechnol 2007;5:3–12
   PubMedGoogle Scholar
• Yang M, Pan HL, Xu HL. Determination of curcumin in GanZhiPing capsules by RPHPLC. Acta Chromatogr 2006;3:109–22
   Google Scholar
• Lakshmi V, Srivastava S, Mishraa SS, et al. In vitro and in vivo antifilarial potential of marine sponge, Haliclona exigua (Kirkpatrick) against human lymphatic filarial parasite Brugia malayi. Parasitol Res 2009;105:1295–301
   PubMed Web of Science ®Google Scholar
• Misra S, Chaterjee RK, Sen AB. The response of litomosides carinii to antifilarial agents in cotton rats Sigmodon hispidus and multimammate rat. Indian J Med Res 1984;79:749–52
   PubMed Web of Science ®Google Scholar
• Taylor MJ, Bilo K, Cross HF, et al. 16 S rDNA phylogeny and ultra structural characterization of Wolbachia intracellular bacteria of filarial nematodes, Brugia malayi, Brugia pahangi and Wuchereria bancrofti. Exp Parasitol 1999;91:356–61
   PubMed Web of Science ®Google Scholar
• Donald E, Nicholas A, Peppas A. Opsonization, biodistribution, and pharmacokinetics of polymeric nanoparticles. Int J Pharm 2006;307:93–102
   PubMed Web of Science ®Google Scholar
• Ali M, Afzal M, Bhattacharya SM, et al. Nanopharmaceuticals to target antifilarials: a comprehensive review. Expert Opin Drug Deliv 2013;10:665–78
   PubMed Web of Science ®Google Scholar
• Ali M, Afzal M, Kaushik U, et al. Perceptive solutions to anti-filarial chemotherapy of lymphatic filariasis from the plethora of nanomedical sciences. J Drug Target 2014;22:1–13
   Google Scholar
• Vishal Gupta N, Shivakumar HG. Development of a drug delivery system superporous hydrogel. Trop J Pharma Res 2010;9:257–64
   Web of Science ®Google Scholar
• Bertrand N, Fleischer JG, Wasan KM, Leroux JC. Pharmacokinetics and biodistribution of N-isopropylacrylamide copolymers for the design of pH-sensitive liposomes. Biomaterials 2009;30:2598–605
   PubMed Web of Science ®Google Scholar
• Feng SS. Nanoparticles of biodegradable polymers for new concept chemotherapy. Expert Rev Med Devices 2004;1:115–25
   PubMed Web of Science ®Google Scholar
• Sahu A, Bora U, Kasoju N, Goswami P. Synthesis of novel biodegradable and self-assembling methoxy poly(ethylene glycol)–palmitate nanocarrier for curcumin delivery to cancer cells. Acta Biomater 2008;4:1752–61
   PubMed Web of Science ®Google Scholar
• Ma Z, Haddadi A, Molavi O, et al. Micelles of poly(ethylene oxide)-b-poly(e-caprolactone) as vehicles for the solubilization, stabilization, and controlled delivery of curcumin. J Biomed Mater Res A 2008;86:300–10
   PubMed Web of Science ®Google Scholar
• Parveen S, Sahoo SK. Polymeric nanoparticles for cancer therapy. J Drug Target 2008;16:108–23
   PubMed Web of Science ®Google Scholar
• Lao CD, Ruffin MT, Normolle D, et al. Dose escalation of a curcuminoid formulation. BMC Complement Altern Med 2006;6:10–23
   PubMedGoogle Scholar
• Sharma RA, Euden SA, Platton SL, et al. Phase I clinical trial of oral curcumin: biomarkers of systemic activity and compliance. Clin Cancer Res 2004;10:6847–54
   PubMed Web of Science ®Google Scholar
• Cheng AL, Hsu C, Lin JK. Phase I clinical trial of curcumin, a chemopreventive agent, in patients with high-risk or pre-malignant lesions. Anticancer Res 2001;21:2895–900
   PubMed Web of Science ®Google Scholar
• Hsu CH, Cheng AL. Clinical studies with curcumin. Adv Exp Med Biol 2007;595:471–80
   PubMed Web of Science ®Google Scholar
• Mukherjee M, Misra S, Chatterjee RK. Development of in vitro screening system for assessment of antifilarial activity of compounds. Acta Tropica 1998;70:251–5
   PubMed Web of Science ®Google Scholar
• Bajpai P, Srivastava K, Shakya S, et al. Improvement in the efficacy of existing combination of antifilarials by inclusion of tetracycline in rodent model of Brugian filariasis. Curr Sci 2007;92:655–8
   Web of Science ®Google Scholar
• Kumara A, Saxenab JK, Chauhana MS. Synthesis of 4-amino-5-cyano-2, 6-disubstituted pyrimidines as a potential antifilarial DNA topoisomerase II inhibitors. Med Chem 2008;4:577–85
   PubMed Web of Science ®Google Scholar